1. Shanahan F. Crohn's disease. Lancet. 2002; 359:62–69.
Article
2. Yang S, Yun S, Kim J, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549.
Article
3. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a longterm follow-up of concordance and clinical characteristics. Gastroenterology. 2003; 124:1767–1773.
Article
4. Orholm M, Binder V, Sorensen T, Rasmussen L, Kyvik K. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol. 2000; 35:1075–1081.
5. Orholm M, Munkholm P, Langholz E, Nielsen O, Sorensen T, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991; 324:84–88.
Article
6. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996; 111:597–603.
Article
7. Park J, Yang S, Byeon J, et al. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis. 2006; 12:1146–1151.
Article
8. Silverberg M, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 montreal world congress of gastroenterology. Can J Gastroenterol. 2005; 19(suppl A):S5–S36.
Article
9. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103:3167–3182.
Article
10. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988; 29:990–996.
Article
11. Thompson N, Driscoll R, Pounder R, Wakefield A. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ. 1996; 312:95–96.
Article
12. Spehlmann M, Begun A, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis. 2008; 14:968–976.
Article
13. Halfvarson J, Jess T, Bodin L, et al. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13:1536–1544.
Article
14. Hugot J, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599–603.
Article
15. Ogura Y, Bonen D, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411:603–606.
Article
16. Lee G, Kim C, Kim J, Jung H, Song I. Frequency analysis of NOD2 gene mutations in Korean patients with Crohn's disease. Korean J Gastroenterol. 2005; 45:162–168.
17. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002; 123:86–91.
Article
18. Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology. 2007; 133:1327–1339.
Article
19. Yang SK, Park M, Lim J, et al. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm Bowel Dis. 2009; 15:1385–1390.
Article